Bio-Rad Laboratories (BIO) Goodwill (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Goodwill for 18 consecutive years, with $574.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Goodwill fell 1.26% year-over-year to $574.3 million in Q2 2026; TTM through Jun 2026 was $574.3 million, a 1.26% decrease from a year earlier, with the FY2025 full-year figure at $579.8 million, up 41.24% from the prior year.
• Goodwill was $574.3 million for Q2 2026 at Bio-Rad Laboratories, roughly flat from $577.1 million in the prior quarter.
• Over five years, Goodwill peaked at $581.6 million in Q2 2025 and troughed at $345.7 million in Q1 2022.
• A 5-year average of $449.8 million and a median of $412.5 million in 2024 frame the typical range for Goodwill.
• Across the five-year window, Goodwill surged 41.24% in 2025 and fell 1.26% in 2026, its largest moves.
• Over 5 years, Goodwill stood at $406.5 million in 2022, then gained by 1.75% to $413.6 million in 2023, then slipped by 0.75% to $410.5 million in 2024, then soared by 41.24% to $579.8 million in 2025, then decreased by 0.95% to $574.3 million in 2026.
• The last three Goodwill figures came in at $574.3 million (Q2 2026), $577.1 million (Q1 2026), and $579.8 million (Q4 2025), per Business Quant data.